Koelis
Koelis is a French medical technology company that develops MRI/Ultrasound fusion biopsy systems with proprietary Organ-Based Tracking for prostate cancer diagnosis and focal therapy, serving urologists and hospitals across 50+ countries through direct enterprise sales.
- Company typePrivate
- Founded2006
- HeadquartersMeylan, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Koelis does
Koelis is a privately held French medical technology company founded in 2006 in Meylan (near Grenoble), France, by Antoine Leroy (CEO) and Patrick Henri. The company specializes in MRI/Ultrasound fusion biopsy systems for prostate cancer diagnosis and treatment, serving urologists, radiologists, and hospitals across more than 50 countries. Its flagship product, KOELIS Trinity, is a mobile fusion imaging platform that combines proprietary 3D ultrasound technology with patented Organ-Based Tracking Fusion (OBT Fusion), which tracks the prostate itself rather than the ultrasound probe to compensate for organ deformation and patient movement during biopsy procedures.
The company's technology platform extends across the full clinical workflow from diagnosis to treatment. Core technologies include OBT Fusion for millimeter-precision needle guidance, 2nd Look Fusion for superimposition of prior biopsy sessions to support active surveillance, and ProMap Smart, an AI-assisted auto-contouring software trained on 8,000+ expert-annotated images that achieves 98% prostate segmentation accuracy in under 5 seconds. Supporting products include ProMap Contour and ProMap Lite for MRI annotation workflows, transperineal and transrectal needle guides (consumables), the Steady Pro probe holder, and a range of 3D ultrasound probes. The VIOLETTE clinical trial has demonstrated 81% of patients remaining free from clinically significant cancer at 12 months following Targeted Microwave Ablation focal therapy.
Koelis operates a direct enterprise sales model through wholly-owned subsidiaries in France (HQ), the United States (2015), Singapore (2019), and Germany (2022), supported by territory managers and clinical application specialists. Revenue derives from capital equipment sales (KOELIS Trinity systems, ultrasound probes), recurring consumables (single-use needle guides), software licenses and AI modules (ProMap family), and annual maintenance contracts. To date, approximately 300,000 patients have been treated using Koelis technology, validated by 80+ peer-reviewed clinical publications. The company has raised funding from Medevice Capital (2011) and InnovaHealth Partners (2019 equity round, 2022 Series B), with no public market listing.
Koelis firmographics
Firmographics- Name
- Koelis
- Legal name
- Koelis SAS
- Website
- https://koelis.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Koelis is a French medical technology company that develops MRI/Ultrasound fusion biopsy systems with proprietary Organ-Based Tracking for prostate cancer diagnosis and focal therapy, serving urologists and hospitals across 50+ countries through direct enterprise sales.
- Ownership category
- akta.pro rank
Koelis industry classification
Industry- Product category
- Medical Imaging Equipment - MRI/Ultrasound Fusion Biopsy Systems for Prostate Cancer
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)
- akta.pro secondary industries
- Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH), Portable, Mobile & Point-of-Care Imaging Systems (HLAHABAL), Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
Keywords
Where Koelis is headquartered
LocationHeadquarters
- HQ city
- Meylan
- HQ country
- France
- HQ region
- Europe
Offices4 records
Markets served
Koelis business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Medical Device Hardware Sales: Sale of KOELIS Trinity fusion biopsy systems, 3D ultrasound probes (transperineal and transrectal), needle guides, and accessories including Steady Pro probe holder. The system is a mobile, integrated ultrasound platform requiring capital equipment purchase by hospitals.
- Software Licenses and Subscriptions: ProMap software products (Smart, Contour, Lite) provide AI-assisted contouring and MRI annotation capabilities. Software may include annual licenses with updates and support as part of the offering.
- Consumables: Single-use needle guides (transperineal and transrectal) generate recurring consumable revenue from procedure volume at customer sites.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Enterprise capital equipment pricing |
| Subscription | Annual | Maintenance and support contracts |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Koelis product offering
Product offeringCore offering
Koelis designs, manufactures, and sells the KOELIS Trinity, a mobile MRI/ultrasound fusion imaging platform used by urologists to perform targeted prostate biopsies and focal therapy procedures. The system combines proprietary Organ-Based Tracking (OBT) Fusion technology with robotic 3D ultrasound and is sold alongside needle guides, ultrasound probes, and the AI-assisted ProMap software family.
Product overview
Koelis offers a unified platform-plus-modules architecture centered on the KOELIS Trinity fusion biopsy system. The core platform combines 3D ultrasound with MRI-US elastic fusion and proprietary OBT Fusion organ tracking technology. Supporting modules include ProMap Smart (AI-assisted auto-contouring), ProMap Contour (third-party AI MRI compatibility), and ProMap Lite (radiology software for pre-fusion MRI preparation). Accessories include transperineal/transrectal needle guides, the Steady Pro probe holder, and a comprehensive range of 3D ultrasound probes (transperineal, transrectal, linear, and abdominal). Key technologies include OBT Fusion for organ-based tracking, 2nd Look Fusion for repeat biopsy procedures, and 3D Ultrasound with robotic beam technology.
Differentiator
Problem solved
Functional benefit
Brands
- ProMap Smart: AI-powered prostate segmentation software that achieves 98% accuracy in automating prostate contouring on MRI scans in under five seconds
- ProMap Contour
- ProMap Lite
- KOELIS Trinity
- OBT Fusion
- 2nd Look Fusion
- 3D Ultrasound
- Steady Pro
- TMA (Targeted Microwave Ablation)
Products and services
- KOELIS Trinity Fully integrated mobile MRI/ultrasound fusion imaging platform that combines 3D ultrasound with OBT Fusion organ-based tracking to provide accurate needle guidance for prostate biopsies and focal therapy procedures, sold as capital equipment to hospitals and cancer centers.
- ProMap Smart AI-assisted auto-contouring software add-on for the KOELIS Trinity that automates prostate segmentation on MRI and ultrasound images, enabling standardized and faster fusion biopsy workflows for radiologists and urologists.
- ProMap Contour Software module that makes the KOELIS Trinity compatible with third-party AI MRI formats, allowing radiologists to perform MRI contouring on dedicated software and import annotated images into the Trinity in three clicks.
- ProMap Lite Radiology software for pre-fusion MRI biopsy preparation, providing three-point prostate contouring with a semi-automated algorithm, 3D lesion contouring, and PI-RADS scoring for accurate biopsies.
- TP & TR Range Needle Guides Single-use and reusable needle guides for transperineal and transrectal prostate biopsy approaches, including Perine Mini Grid, Perine Full Grid, Perine Nail, and disposable/reusable transrectal guides designed for use with the KOELIS Trinity.
- Steady Pro Mechanical prostate probe holder that assists physicians in performing optimal targeted biopsies and treatments by reducing movement restrictions and helping maintain convenient probe positions for both transrectal and transperineal approaches.
- Ultrasound Probes Comprehensive range of 3D ultrasound probes compatible with KOELIS Trinity, including transperineal side-fire (K3DEL00 / K3DEL00-2, 4-9 MHz), transrectal end-fire (K3DEC00-2, 4-9 MHz), linear (K2DLN00, 7-15 MHz), and abdominal (K2DAB00, 2-5 MHz) probes.
Quantifiable outcome
- 98% AI contouring accuracy achieved in under 5 seconds with ProMap Smart
- +5 more outcomes
Companies that use Koelis
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles1 record
Koelis technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability2 records
Feature6 records
Koelis partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- DeepHealthcoreKoelis partnered with DeepHealth to integrate DeepHealth's AI-powered Prostate software with the Koelis Trinity 3D Ultrasound Platform. The integration streamlines prostate MRI reading and lesion detection, allowing radiologists to import AI-contoured sequences into Koelis Trinity for improved workflow efficiency in fusion biopsy procedures.
- Bot ImagecoreKoelis Trinity is fully integrated with Bot Image AI software for automatic MRI segmentation and lesion detection. Bot Image's Prostate software (North America's first automatic MRI segmentation and lesion detection software) enhances procedural efficiency and workflow for Koelis users.
Scale indicators8 records
Recent moves9 records
Expansion highlights6 records
Koelis competitors and assessment
Company assessmentDirect peers
- Focal Healthcare: Direct competitor offering the Fusion Bx and Fusion MR systems for MRI-ultrasound fusion prostate biopsy, with similar target customers (urology practices and hospitals) and overlapping technology approach.
Broad incumbents
- Philips (UroNav / Eigen): Philips acquired Eigen and markets UroNav, a leading MRI-US fusion biopsy system, alongside a broad imaging portfolio. Overlaps directly with Koelis in fusion-guided prostate biopsy but competes across many other modalities.
- GE HealthCare (BK Medical): GE HealthCare, via BK Medical, offers fusion biopsy ultrasound solutions integrated with its broader imaging ecosystem. Competes with Koelis in fusion-guided prostate biopsy while serving many other imaging segments.
- FUJIFILM Healthcare (Hitachi):
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Koelis social profiles
Digital presenceKoelis compliance and trust
Trust signalCompliance1 record
Koelis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Koelis leadership team
Management profileNumber of profiles
Profiles3 records
Koelis subsidiaries and ownership
Company hierarchySubsidiaries3 records
Koelis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Koelis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Koelis
What does Koelis do?
Koelis designs, manufactures, and sells the KOELIS Trinity, a mobile MRI/ultrasound fusion imaging platform used by urologists to perform targeted prostate biopsies and focal therapy procedures. The system combines proprietary Organ-Based Tracking (OBT) Fusion technology with robotic 3D ultrasound and is sold alongside needle guides, ultrasound probes, and the AI-assisted ProMap software family.
Is Koelis a public or private company?
Koelis is a private company. It is classified as venture growth investor backed and is currently operating.
When was Koelis founded?
Koelis was founded in 2006. It employs 11 to 50 people.
Where is Koelis based?
Koelis is headquartered in Meylan, France, in the Europe region.
How does Koelis make money?
Three revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are software Licenses and Subscriptions and consumables.
Who are Koelis's main competitors?
Focal Healthcare is listed as a direct peer. Broad incumbents are Philips (UroNav / Eigen), GE HealthCare (BK Medical) and FUJIFILM Healthcare (Hitachi).
Does Koelis have an API?
No public API is recorded for Koelis.
What industry is Koelis in?
Koelis's product category is Medical Imaging Equipment - MRI/Ultrasound Fusion Biopsy Systems for Prostate Cancer. Its primary akta.pro industry code is HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems, with a secondary code of HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence). Its NAICS code is 334510 and its SIC code is 3841.